E3 PreliminaryPreliminaryPEM not requiredReview-NarrativePeer-reviewedReviewed
Standard · 3 min
The role of enterovirus in chronic fatigue syndrome.
Chia, J K S · Journal of clinical pathology · 2005 · DOI
Quick Summary
This review examines whether enteroviruses—common viruses that cause respiratory and stomach infections—might play a role in ME/CFS. Researchers found that these viruses can sometimes persist in the body long-term and produce symptoms similar to ME/CFS. Laboratory and animal studies showed that viral RNA (genetic material) can remain in muscles and cause ongoing inflammation, which matches what has been seen in tissue samples from ME/CFS patients.
Why It Matters
This work reopens investigation into enterovirus as a potential ME/CFS mechanism after a decade of neglect, bridging basic viral biology with clinical symptomatology. If enteroviral persistence is confirmed in ME/CFS, it could eventually lead to diagnostic tests and antiviral treatment strategies for patients currently lacking biological markers or targeted therapies.
Observed Findings
In vitro and animal model studies demonstrated chronic enteroviral persistence through formation of double-stranded RNA
Muscle biopsies from CFS patients showed findings similar to those observed in chronic enteroviral infection models
Antiviral treatment responses provided evidence supporting a pathogenic role of viral RNA in CFS
Enteroviruses demonstrate tropism for the central nervous system, muscles, and heart—tissues affected in CFS
Inferred Conclusions
Enteroviral persistence may represent a biological mechanism underlying symptoms in some ME/CFS patients
Viral RNA-mediated inflammation could explain the chronic muscle symptoms and neurological features observed in CFS
Antiviral approaches warrant further investigation as potential therapeutic targets
Remaining Questions
Which specific enterovirus species are most commonly associated with ME/CFS, and how prevalent is chronic enteroviral infection in the broader CFS population?
What determines whether some individuals develop chronic viral persistence while others recover after acute infection?
Would antiviral therapies be effective in treating ME/CFS patients with confirmed enteroviral persistence, and what are the long-term safety and efficacy profiles?
What This Study Does Not Prove
This review does not establish that enterovirus causes all cases of ME/CFS or even that it is the primary cause in affected patients. It demonstrates a plausible mechanism and some supportive evidence, but does not prove that viral persistence is necessary or sufficient for disease development, nor does it rule out other contributing factors.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
Are there reliable diagnostic methods to detect enteroviral persistence in patients, distinguishing it from other potential causes of CFS-like illness?